3Floreani A, Guido M, Bortolami M, Della Zentil G, Venturi C,Pennelli N, Naccarato R. Relationship between apoptosis, tumour necrosis factor, and cell proliferation in chronic cholestasis. Dig Liver Dis 2001;33:570-575.
4Kaplowitz N. Cell death at the millennium. Implications for liver diseases. Clin Liver Dis 2000;4:1-23.
5Rodrigues CM, Steer CJ. Bile acids and hepatocyte apoptosis:living/leaving life in the Fas lane. Gastroenterology 1999;117:732-736.
6Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol 2001;16:3-14.
7Rodrigues CM, Steer CJ. The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent. Expert Opin Investig Drugs 2001;10:1243-1253.
8Marzioni M, Glaser SS, Alpini G, LeSage GD. Role of apoptosis in development of primary biliary cirrhosis. Dig Liver Dis 2001;33:531-533.
9Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001;33:616-626.
10Chen Q, Gong B, Almasan A. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death Differ 2000;7:227-233.
